fundvisualizer.com

GMO International Equity IVGMCFX

Performance (before sales charge)

As of 04/30/2023

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 02/28/2023
Stock
0.37%
Non-U.S. Stock
96.15%
Bond
2.93%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
2.45%
Other
-1.89%

Due to rounding, percentages may not equal 100%.

Sectors

As of 02/28/2023

Basic materials

6.21%

Consumer cyclical

12.12%

Financial services

13.92%

Real estate

0.48%

Consumer defensive

12.89%

Health care

9.78%

Utilities

0.36%

Communication services

5.83%

Energy

7.78%

Industrials

19.76%

Technology

7.42%

Top 10 holdings

As of 02/28/2023

GMO US Treasury
5.07%
Other Liability
3.85%
Roche Holding AG
3.09%
TotalEnergies SE
3.03%
Banco Bilbao Vizcaya Argentaria SA
2.84%
Compagnie de Saint-Gobain SA
2.64%
Sanofi SA
2.61%
STMicroelectronics NV ADR
2.60%
Rio Tinto Ltd
2.59%
British American Tobacco PLC
2.49%
Fund assets

$1.23 Billion

Share class

Other

Morningstar category

Foreign Large Value

Expense ratio

0.62%

Investment objective

Foreign Stock

Documents